Australian Medical Device Framework Takes Effect; Reuse Is On Horizon
This article was originally published in The Gray Sheet
Executive Summary
Sponsors of the 20% of CE-marked Class I, Class IIa and Class IIb devices randomly selected to undergo an audit by Australia's Therapeutic Goods Administration will pay additional fees under the country's new medical device framework, which took effect Oct. 4